Skip to content

PTSD research published in 2024

95 studies whose primary subject is PTSD were published in 2024, up from 87 in 2023. Newest first. Back to the PTSD overview

Studies

Depression, post-traumatic stress disorder, suicidal ideation and ketamine: a case report.

Journal of Medical Case Reports December 24, 2024 S Asad, K Latifzai, V T Eliopoulos et al. 1 citation

Ketamine treatment presents a novel approach for addressing refractory conditions, such as major depressive disorder, suicidal ideation, and posttraumatic stress disorder, which often co-occur and pose significant challenges for clinicians. This study explores the clinical and electrophysiological outcomes of ketamine treatment in two cases, shedding light on its potential efficacy and...

Effectiveness of Meditation Techniques in Treating Post-Traumatic Stress Disorder: A Systematic Review and Meta-Analysis.

Medicina (Kaunas, Lithuania) December 12, 2024 David W. Orme-Johnson, Vernon A Barnes, Brian Rees et al. 5 citations

Background and Objectives: Post-traumatic stress disorder (PTSD) is a debilitating condition worldwide. The limited effectiveness of current psychological and pharmacological treatments has motivated studies on meditation techniques. This study is a comprehensive, multiple-treatments meta-analysis comparing the effectiveness of different categories of meditation in treating PTSD. Methods and...

MDMA for PTSD and beyond: a new paradigm brings hope.

Frontiers in Human Neuroscience December 11, 2024 Scott Shannon, Jamarie Geller 3 citations

We are experiencing a mental health crisis of unprecedented proportions. Over the last two decades this crisis grew from a perfect storm of rising insurance deductibles, escalating social stressors, the COVID-19 pandemic, and a critical workforce deficiency. Perhaps no mental health arena has a greater shortfall of effective treatment options than Post-traumatic Stress Disorder (PTSD) as the...

Benefits of Meditation Practices in Alleviating Posttraumatic Stress Disorder (PTSD) Symptoms for Individuals Already in Therapy

Pacific Journal of Health December 8, 2024 Jeanette G Mann, Lindsay Gietzen

Abstract This study examines the impact of adding and incorporating a meditation practice into a treatment plan for Posttraumatic Stress Disorder (PTSD) for three adult patients at a Federally Qualified Health Center (FQHC). The cases involved included patients with persistent PTSD symptoms who had experienced limited improvement with standard therapies. Data from Electronic Health Records and...

Six Month Follow up of the one of the First Patients to Complete MDMA-Assisted Therapy for PTSD Outside of Clinical Trials in Australia: Implications for Translating Clinical Research to Clinical Practice

International Journal of Psychology December 6, 2024 Monica Schweickle, Ted Cassidy

Purpose: The goal of this case report is to illustrate the implementation of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy for posttraumatic stress disorder (PTSD) and learning points for health professionals in the translation of psychedelic assisted therapy research into clinical practice. We present our key learnings and 6-month follow up data from one of the first patients to...

The effect of mindfulness-based cognitive therapy on PTSD and depression symptoms in trauma-exposed black adults: Pilot randomized controlled trial results.

Journal of Mood and Anxiety Disorders December 1, 2024 Malin Au, Rebecca Lipschutz, Yara Mekawi et al. 4 citations

Low-income, urban-dwelling Black adults are disproportionately affected by traumatic experiences, post-traumatic stress disorder (PTSD), and depression and encounter inequities in treatment access. In addition to the benefits Mindfulness-Based Cognitive Therapy (MBCT) for depression, there is preliminary evidence of successful symptom reduction in PTSD via MBCT across two prior pilot studies in...

DOI: 10.1016/j.xjmad.2024.100092 (opens in new tab) Full text (opens in new tab) Major depressive disorder Mindfulness-based cognitive therapy Posttraumatic stress disorder

(2R,6R)-hydroxynorketamine alleviates PTSD-like endophenotypes by regulating the PI3K/AKT signaling pathway in rats.

Pharmacology, Biochemistry, and Behavior December 1, 2024 Lifen Liu, Rui Li, Lanxia Wu et al. 3 citations

Patients diagnosed with post-traumatic stress disorder (PTSD) mainly exhibit enduring adverse emotions, heightening susceptibility to suicidal thoughts and behaviors. Notably, metabolites of ketamine, particularly (2R,6R)-hydroxyketamine (HNK), have demonstrated favorable antidepressant properties. However, the precise mechanism through which HNK exerts its therapeutic effects on negative...

MDMA-assisted psychotherapy for the treatment of PTSD: A systematic review and meta-analysis of randomized controlled trials (RCTs).

Neuropsychopharmacology Reports December 1, 2024 Ghada Shahrour, Kainat Sohail, Safa Elrais et al. 21 citations

Post-traumatic stress disorder (PTSD) is a mental health disorder resulting from exposure to traumatic events, manifesting in various debilitating symptoms. Despite available treatments, many individuals experience inadequate response or significant side effects. Previous reviews suggest promising outcomes with MDMA-assisted psychotherapy (MDMA-AT), but limitations prompt the need for a...

Novel Pharmacologic and Other Somatic Treatment Approaches for Posttraumatic Stress Disorder in Adults: State of the Evidence.

American Journal of Psychiatry December 1, 2024 Lauren M. Sippel, Jessica L. Hamblen, Benjamin Kelmendi et al. 11 citations

Posttraumatic stress disorder (PTSD) is a highly prevalent psychiatric disorder that can become chronic and debilitating when left untreated. The most commonly recommended first-line treatments for PTSD among adults are individual trauma-focused psychotherapies. Other evidence-based treatments include specific antidepressant medications and non-trauma-focused psychotherapies. Despite the...

DOI: 10.1176/appi.ajp.20230950 (opens in new tab) Full text (opens in new tab) Behavioral psychotherapy Cognitive psychotherapy Drug psychotherapy combination Evidence-based treatment +6

Ayahuasca in the treatment of posttraumatic stress disorder: Mixed-methods case series evaluation in military combat veterans.

Psychological Trauma: Theory, Research, Practice and Policy December 1, 2024 Brandon Weiss, Lê-Anh Dinh-Williams, Nick Beller et al. 16 citations

[Correction Notice: An Erratum for this article was reported online in Psychological Trauma: Theory, Research, Practice, and Policy on Jul 25 2024 (see record 2025-07042-001). In the original article, there was an error in the calculations that led to the overstatement of the symptom severity of the veteran sample. Specifically, sum scores for the posttraumatic stress disorder (PTSD) symptom...

DOI: 10.1037/tra0001625 (opens in new tab) Full text (opens in new tab) PTSD-Treatment Psychedelic-therapy Veterans-health Trauma-recovery +1

Correction to "Ayahuasca in the treatment of posttraumatic stress disorder: Mixed-methods case series evaluation in military combat veterans" by Weiss et al. (2023).

Psychological Trauma: Theory, Research, Practice and Policy December 1, 2024 correction

Reports an error in "Ayahuasca in the treatment of posttraumatic stress disorder: Mixed-methods case series evaluation in military combat veterans" by Brandon Weiss, Lê-Anh L. Dinh-Williams, Nick Beller, Ian M. Raugh, Gregory P. Strauss and William K. Campbell (Psychological Trauma: Theory, Research, Practice, and Policy, Advanced Online Publication, Dec 07, 2023, np). In the original article,...

DOI: 10.1037/tra0001730 (opens in new tab) Full text (opens in new tab) Psychedelic therapy Veterans mental health Ayahuasca treatment Trauma recovery +1

Low dose oral ketamine treatment on post-traumatic stress disorder (PTSD) (OKTOP): An open-label pilot study

medRxiv Preprint Server November 26, 2024 Bonnie L. Quigley, Adem T. Can, Megan Dutton et al. 1 citation preprint

Ketamine is being actively investigated as a rapid-acting treatment for many conditions with a stress-related psychopathology, including post-traumatic stress disorder (PTSD). The majority of studies regarding ketamine treatment for PTSD to date (including open-label and randomised control trials) have focused on intravenous (IV) ketamine administration. This administration route has...

DOI: 10.1101/2024.11.26.24318024 (opens in new tab) Full text (opens in new tab) Low-dose oral ketamine PTSD Treatment PTSD Therapy PTSD Relief +8

Author Correction: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.

Nature Medicine November 1, 2024 Jennifer Mitchell, Marcela Ot’alora G., Bessel Van der Kolk et al. 4 citations

In the version of the article initially published, some members of the MAPP2 Study Collaborator Group were listed only in the Supplementary Information. Charlotte Harrison, Berra Yazar-Klosinski, Wael Garas, Darrick May, Cole Marta, Susan Walker, Elizabeth Nielson, Gregory Wells, Randall Brown, Revital Amiaz, Yair Wallach, Ray Worthy, Alia Lilienstein and Amy Emerson have now been added to the...

MDMA-assisted psychotherapy for PTSD in adolescents: rationale, potential, risks, and considerations.

European Child & Adolescent Psychiatry November 1, 2024 Samuli Kangaslampi, Josjan Zijlmans 18 citations

3,4-Methylenedioxymetamphetamine(MDMA)-assisted psychotherapy (MDMA-AP) is a proposed treatment for posttraumatic stress disorder (PTSD) that may be approved for adults soon. PTSD is also common among trauma-exposed adolescents, and current treatments leave much room for improvement. We present a rationale for considering MDMA-AP for treating PTSD among adolescents. Evidence suggests that as an...

How Psychedelics Modulate Multiple Memory Mechanisms in Posttraumatic Stress Disorder.

Drugs November 1, 2024 Manoj K. Doss, Annamarie Demarco, Joseph E Dunsmoor et al. 14 citations

Posttraumatic stress disorder (PTSD) is a psychiatric disorder with defining abnormalities in memory, and psychedelics may be promising candidates for the treatment of PTSD given their effects on multiple memory systems. Most PTSD and psychedelic research has investigated memory with fear conditioning and extinction. While fruitful, conditioning and extinction provide a limited model of the...

Serotonin Transporter (SLC6A4) and FK506-Binding Protein 5 (FKBP5) Genotype and Methylation Relationships with Response to Meditation in Veterans with PTSD.

Molecular Neurobiology November 1, 2024 Adam M Lee, Paul Thuras, Joshua Baller et al. 9 citations

Meditation-based interventions are novel and effective non-pharmacologic treatments for veterans with PTSD. We examined relationships between treatment response, early life trauma exposure, DNA polymorphisms, and methylation in the serotonin transporter (SLC6A4) and FK506-binding protein 5 (FKBP5) genes. DNA samples and clinical outcomes were examined in 72 veterans with PTSD who received...

DOI: 10.1007/s12035-024-04096-6 (opens in new tab) Full text (opens in new tab) Mindfulness-based stress reduction Posttraumatic stress disorder Serotonin transporter slc6a4 Transcendental meditation

Feasibility and effects of mindfulness-based stress reduction (MBSR) for improving resilience, posttraumatic stress disorder symptoms and posttraumatic growth among military medical college students.

Acta Psychologica November 1, 2024 Xiaofan Yan, Xiaojie Wang, Yanli Chen et al. 11 citations

Increased stress among medical students in military college has been a challenge in the field of education. One approach to addressing stress reduction is mindfulness training. MBSR has been verified to improve the health status of different individuals. The aim of this study was to examine whether MBSR improves the psychological resilience, posttraumatic stress and posttraumatic growth of...

Evaluating the mobile Mantram Repetition Program for veterans with PTSD: A multimethod randomized feasibility trial of self-directed versus text support delivery.

Psychological Trauma: Theory, Research, Practice and Policy October 31, 2024 Caitlin L Mclean, Ashley Faytol, Gage Chu et al. 1 citation

While mobile delivery can help increase access to evidence-based treatment for veterans with posttraumatic stress disorder (PTSD), feasibility and acceptability are of concern with the potential for high attrition rates and limited participation. The Mantram Repetition Program (MRP), a meditation-focused approach with documented efficacy for reducing symptoms of PTSD and insomnia, was adapted...

The Relationship between Neuroticism, Nightmare Characteristics and Suffering in respect to PTSD Psychopathology

Primenjena psihologija October 30, 2024 Sonja Protic, Robert-Jacek Gorzka, Helge Höllmer et al.

Introduction: The role of neuroticism in the relationship between nightmare characteristics (e.g., frequency and replicativity), and nightmare-related suffering, i.e., nightmare-related distress and impairment after awaking, is still to be explored. Methods: In a sample of 346 soldiers (mean age 33.95 years, 13.9% females) who experienced at least one traumatic event (47.0% having a formal...

DOI: 10.19090/pp.v17i3.2505 (opens in new tab) Nightmare Neuroticism Psychopathology Clinical psychology +3